Figure 1From: Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial) Flow chart of subjects included in the trial. Number of patients screened was not determined. All patients completed one-year follow-up. ACS, acute coronary syndrome.Back to article page